Title
Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis
Date Issued
2020
Access level
open access
Resource Type
journal article
Author(s)
Oliveira-de-Souza D.
Vinhaes C.L.
Kumar N.P.
Queiroz A.T.L.
Fukutani K.F.
Babu S.
Andrade B.B.
Fundação Oswaldo Cruz, Instituto Gonçalo Moniz
Publisher(s)
Nature Research
Abstract
Tuberculosis (TB) is a chronic infection that can affect individuals of all ages. The description of determinants of immunopathogenesis in TB is of tremendous interest due to the perspective of finding a reliable host-directed therapy to reduce disease burden. The association between specific biomarker profiles related to inflammation and the diverse clinical disease presentations in TB has been extensively studied in adults. However, relatively scarce data on profiling the inflammatory responses in pediatric TB are available. Here, we employed the molecular degree of perturbation (MDP) score adapted to plasma biomarkers in two distinct databanks from studies that examined either adults or children presenting with pulmonary or extrapulmonary disease. We used multidimensional statistical analyses to characterize the impact of age on the overall changes in the systemic inflammation profiles in subpopulation of TB patients. Our findings indicate that TB results in significant increases in molecular perturbation, with the highest values being detected in adult patients. Furthermore, there were unique differences in the biomarker perturbation patterns and the overall degree of inflammation according to disease site and age. Importantly, the molecular degree of perturbation was not influenced by sex. Our results revealed that aging is an important determinant of the differences in quality and magnitude of systemic inflammatory perturbation in distinct clinical forms of TB.
Volume
10
Issue
1
Language
English
OCDE Knowledge area
Sistema respiratorio
Geriatría, Gerontología
Scopus EID
2-s2.0-85087800627
PubMed ID
Source
Scientific Reports
ISSN of the container
20452322
Sponsor(s)
1Fundação?Oswaldo?Cruz,?Instituto?Gonçalo?Moniz,?Salvador?40296-710,?Brazil.?2Multinational Organization Network?Sponsoring?Translational? and?Epidemiological?Research?(MONSTER)?Initiative,?Salvador?41810-710,? Brazil.?3Curso?de?Medicina,?Faculdade?de?Tecnologia?e?Ciências?(UniFTC),?Salvador?40290-150,?Brazil.?4International Center?for?Excellence?in?Research,?National?Institutes?of?Health-?National?Institute?for?Research?in?Tuberculosis,? Chennai?600031,?India.?5Laboratory?of?Parasitic?Diseases,?NIAID,? NIH,?Bethesda?20892,?USA.?6Escola?Bahiana? de?Medicina?e?Saúde?Pública?(EBMSP),?Salvador?40290-000,?Brazil.?7Laureate Universities, Universidade Salvador?(UNIFACS),?Salvador?41720-200,?Brazil.?8Wellcome? Centre?for?Infectious?Diseases?Research?in?Africa? (CIDRI-Africa),?Institute?of?Infectious?Disease?and?Molecular?Medicine,?University?of?Cape?Town,? Cape?Town?7925,? South?Africa.?9These?authors?contributed?equally:?Deivide?Oliveira-de-Souza?and?Caian?L.?Vinhaes.*email: bruno.andrade@fiocruz.br
The authors acknowledge study participants. This project was supported by the Intramural Research Program of the NIAID to S.B. and N.P.K. This study was also financed in part by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (Finance Code 001). The work of B.B.A. was supported by grants from the NIH (U01AI115940, R01AI069923-08, R01AI20790-02), by Intramural Program of Fundação Oswaldo Cruz and by the Brazilian National Council for Scientific and Technological Development (CNPq–bolsa de produtividade 1D). D.O.S. and M.B.A. receive fellowships from the Fundação de Amparo à Pesquisa da Bahia (FAPESB). C.L.V. is a research fellow and K.F.F. is a postdoctoral fellow from CNPq.
Sources of information:
Directorio de Producción Científica
Scopus